Corporate ActionSep 11, 2026, 05:33 PM
Dyadic International Files to Register 3.6M Shares for Resale by Stockholders
AI Summary
Dyadic International, Inc. (DYAI) has filed an S-1 registration statement to allow selling stockholders to resell up to 3,625,000 shares of common stock. These shares are issuable upon the exercise of warrants with an exercise price of $0.84 per share. The company will not receive proceeds from the resale of these shares, only from the potential exercise of the warrants. As of September 10, 2026, there were 40,063,703 shares outstanding, and the stock last traded at $0.49. Dyadic International is a biotechnology company focused on developing and commercializing recombinant proteins and enzymes.
Key Highlights
- Dyadic International, Inc. is registering up to 3,625,000 shares of common stock for resale by selling stockholders.
- These shares are issuable upon the exercise of warrants at an exercise price of $0.84 per share.
- The company will receive proceeds only if warrants are exercised; no proceeds from the resale of shares.
- As of September 10, 2026, 40,063,703 shares of common stock were outstanding.
- The last reported sale price of DYAI common stock on Nasdaq was $0.49 per share on September 10, 2026.
- The company is a smaller reporting company and an emerging growth company.
- Dyadic International, Inc. develops, manufactures, and commercializes recombinant proteins and enzymes.
Price Impact
More from DYAI